Search Authors: Yeshim Deniz, Carmen Gonzalez, Lori MacVittie, Liz McMillan, Shelly Palmer

News Feed Item

Global Proteomics Industry

NEW YORK, Dec. 5, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:


Global Proteomics Industry



This report analyzes the worldwide markets for Proteomics in US$ Million by the following Product Segments: Expression Proteomics, Functional Proteomics, and Structural Proteomics. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period of 2010 through 2015. Also, a six-year historic analysis is provided for these markets. The report profiles 111 companies including many key and niche players such as ActivX Biosciences, Inc., Adnexus Therapeutics, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Bruker Daltonics, Inc., Caprion Proteomics, Inc., Digilab Genomic Solutions, Inc., Dionex Corporation, GE Healthcare, Geneva Bioinformatics S.A., Hybrigenics SA, Life Technologies Corporation, Millipore Corp., PerkinElmer, Inc., Caliper Life Sciences, Shimadzu Biotech, Sigma-Aldrich Corporation, Thermo Fisher Scientific, Waters Corp., Xencor Inc., and Zyomyx, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.





Study Reliability and Reporting Limitations I-1

Disclaimers I-2

Data Interpretation & Reporting Level I-2

Quantitative Techniques & Analytics I-3

Product Definitions and Scope of Study I-3

Expression Proteomics I-3

Functional Proteomics I-3

Structural Proteomics I-4






Proteomics - The Current Spotlight II-1

Market Drivers II-1

Transition from Genomics to Proteomics II-1

Industrialization of Proteomics Research II-2

International Initiatives Light-up Proteomics Market II-2

Factors Limiting Market Growth II-2

Economic Recession Impact on the Life Sciences Industry in

Retrospect II-2

Biotechnology Sector - Affected by Collapse of Capital Market II-3

Tough Times for Market Participants II-3

Proteomics Technologies: Growing in Significance II-4

Transformation of Drug Discovery through Proteomics and Genomics II-5

Proteomics: A Critical Drug Discovery Tool II-5

China All Set To Play a Major Role in the Proteomics Industry II-6

Global Proteomics Sample Preparation Market - On a Growth Curve II-7

Challenges Facing Proteomics Sample Preparation Market II-7

Challenges Facing Proteomics Industry II-7

Protein Chemistry and its Complexities II-7

Integration of Data & Equipment II-7

Data Validation - A Burning Issue II-8

Standardization & Consistency - A Prime Concern II-8

Incomplete and Disorganized Data II-8



Industry Participants II-9

Proteomics Market Worldwide: Competitive Landscape II-9

Proteomics Supplier Market II-9

Tool Providers: Leading the Proteomics Market II-10

Applied Biosystems-Invitrogenc Corporation Merger - A Key

Development II-10

Challenges Ahead II-11

Designing a Novel Business Model II-11

Role of Contract Research Organizations - All Set to Increase

in Proteomics II-11



Proteins, Proteome and Proteomics!!! - What are They? II-12

Proteomics - An Introduction II-12

Genesis of Proteomics II-13

Tales From Times Gone By II-13

Components of Proteomics II-13

Expression Proteomics II-13

Functional Proteomics II-14

Cell-map Proteomics II-14

Structural Proteomics II-14

Technologies and Proteomics II-14

Proteomics and Genomics II-15

Proteomics and Genomics: A Comparison II-15

Protein Production Pathway: From Gene Expression to

Functional Protein with Controls II-15

From Genomics to Proteomics II-16

Functional Genomics and Proteomics II-16

Push From Genomic Information II-17

An Insight into Proteomics Data Type and their

Characteristics / Features II-17

Standard Proteomics Approach II-17

Sample Preparation - Step I II-18

Protein Separation - Step II II-18

Protein Visualization II-18

Protein Expression Analysis-Step III II-18

Protein Identification - Step IV II-19

Data Storage and Processing - Step V II-19



A Snapshot of Various Proteomics Tools II-20

An Insight into Various Proteomics Technologies and their

Application Areas II-20

Protein Separation II-20

2-Dimensional Gel Electrophoresis (2DGE) II-20

Protein Characterization II-22

Analysis of Protein Through Mass Spectrometry II-22

MS and Proteins II-22

Applications of MS II-23

Problems Associated with MS II-24

Types of Analyzers or Filters II-24

Y2H, Yeast 2-Hybrid System II-25

Protein Microarrays II-26

Chip Technology II-26

Microfluidic Applications II-27

Role of Bioinformatics in Proteomics II-27

Bioinformatics Applications and Tools in Proteomics II-27

Emerging Proteomics Technologies II-29

MudPIT II-29


Phage Display Technique II-30

Advanced Proteomics Technologies: Structural Analysis Tools II-30

X-ray Crystallography II-30

Nuclear Magnetic Resonance (NMR) II-30

In silico Modelling II-31

Physicochemical Factors Constraining Metabolic Functions II-31



Proteomics in Drug and Diagnostic Discovery II-33

Proteomics and Drug Discovery II-33

Protein Microarrays: A New Tool for the Development of

Pharmaceuticals II-34

Proteomic Approaches Gain Prominence in Cancer Drug Discovery II-34

Advancements in Proteomics Bring Biomarkers into Limelight II-35



Applied Biomics Introduces Global Protein Post- Translational

Modification II-36

AB SCIEX Launches New Column Chips II-36

Applied Biomics Introduces New Mass Spectrometry Service II-37

Norton Scientific Introduces Novel Specialist Applications

Development Laboratory Service II-37

Gentel Biosciences Introduces APiXTM Disease Profiling Kit II-38

Integromics Introduces OmicsHub Proteomics 2.0 II-38

Bruker Introduces amaZon Speed Ion Trap Mass Spectrometers II-39

Applied Biomics Introduces iTRAQ Service for Proteomics Research II-39

Norton Scientifc Company Introduces New Lab Support Service

for Rapid RNA/DNA and Protein Measurement II-39

Bruker Launches MALDI BiotargetTM II-40

Thermo Fisher Launches UHLPC System II-40

Kinexus Introduces Human Gene Online TranscriptoNET KnowledgeBase II-41

Bruker Launches PRIME Integrated Proteomics Solution II-42

Applied Biosystems Launches LS*LIMS Laboratory Automation

Technology for Proteomics and Genomics II-42

Kinexus Bioinformatics Introduces Online KiNET-AM Proteomics

DataBase II-42

Bruker Rolls Out CaptiveSpray Electrospray Ion Source for

Proteomics Applications II-43

Thermo Fisher Launches New Capabilities for Performing

Proteomics Workflows II-43

National Cancer Institute Introduces Clinical Proteomic Tumor

Analysis Consortium for Cancer Studies II-44

KinaSorbTM' - New Kit for Kinase Enrichment II-45




Gentel Biosciences Unveils Gentel Proteomics Multi-SystemTM II-46

caprotec bioanalytics Introduces Innovative caproKits II-46

Gentel Biosciences Introduces SilverQuant® Simian Pathogen

Array for Health Monitoring of Laboratory Animals II-46

Gentel Biosciences Introduces SilverQuant® Human Tumor

Profiling Kits II-46

Gentel Biosciences Introduces SilverQuant® Disease Profiling Kit II-47

Gentel Biosciences Introduces SilverQuant® View Detection Kits II-47

Gentel Biosciences Launches Proteomics Multi-System II-47

New England Peptide Introduces NEPTune™ Range of Proteomics

Reagents II-48

Applied Biomics Introduces NanoLC-MS/MS Service II-48

Life Technologies Introduces Magic Sample Processor for

Epigenetics, Proteomics Sample Preparation II-49

Integromics Introduces SeqSolve™ NGS Bioinformatics Analysis

Software II-50

Thermo Fisher Scientific Unveils Software Suite for Enhanced

Workflows in Proteomics II-50

Proxeon Introduces EASY-nLC II System for Improved

Productivity in Proteomics (Denmark) II-51

Gentel Biosciences Launches Proteomics Multi-System II-51

Arrayit Discovers New Proteomic Biomarkers II-52

Kinexus Bioinformatics Launches Peptide Development Facility II-52

Bruker Daltonics Unveils ultrafleXtreme™ MALDI-TOF/TOF Mass

Spectrometer II-52

Agilent Technologies Rolls Out HPLC-Chip II-53

Applied Biosystems and MDS Introduce AB SCIEX TOF/TOF™ 5800

System II-53

Applied Biomics Extends Proteomics Service Offerings II-54

AnaSpec Introduces Keratin Antibodies II-54

caprotec bioanalytics Unveils cAMP caproKit and SAH caproKit II-54

Huzhou Sai'erdi Biopharmaceutical Introduces Proteomic

Fingerprint Technology Test Kit II-54



Life Technologies Enters into Partnership with Sino Biological II-55

Proteome Sciences Signs Agreement with CHDI Foundation II-55

Waters Corp. Inks Agreement with Nonlinear Dynamics II-56

BioFocus Enters into Alliance with Activiomics II-56

Great Point Partners Divests Caprion Proteomics II-56

Glaxo Smith Kline Takes Over Cellzome II-57

Emerald BioSystems Changes Name to Emerald Bio II-57

Bruker Unveils Novel Nano-Advance UHPLC System II-57

Evotec Takes Over Kinaxo Biotechnologies II-58

Kinaxo Biotechnologies and AstraZeneca Sign Agreement II-58

Gentel Biosciences Takes Over Eppendorf's SilverQuant Trademark II-58

Thermo Fisher Takes Over Fermentas International II-58

KINAXO to Collaborate with Takeda II-59

Dualsystems and Bulldog Bio Signs Exclusive Marketing Agreement II-59

Novartis Enters into Agreement with SomaLogic II-59

Sage-N Inks Exclusive Pact With the U.S. Army II-59

Proteome Sciences Inks Agreement with Moffitt Cancer Center II-60

Gentel Biosciences Enters into Agreement with Oregon Health &

Science University II-60

Evotec OAI Forms Joint Venture with MeITec to Collaborate on

Drug Discovery Services II-60



MicroBioChips Merges with Biosystems II-61

Caprion Proteomics Acquires Biomarket Unit from PPD Biomarker

Discovery Sciences II-61

ICON Enters into Strategic Alliance with Proteome Sciences II-61

Gentel Enters into Partnership with RayBiotech for

SilverQuant® Chromogenic Detection Platform II-61

Trans-Hit Biomarkers Enters into Alliance with Caprion to

Deliver Proteome-Hit Services II-62

Proteoprep Enters into License Agreement with Sigma-Aldrich II-62

Activiomics Signs Technology Agreement with UCB for Proteomics

Platform(UK/Belgium) II-63

Expression Pathology Enters into Service Partnership with

Flagship for Tissue Proteomics Development II-63

National Cancer Institute Enters into MoU with AACC in

Proteomics Sector II-63

MGL Americas and ProFACT Proteomics Team Up for Biomarker

Discovery II-64

Thermo Fisher Scientific and Luxembourg Clinical Proteomics

Unit Form Collaboration (Luxembourg) II-64

Covance Unveils Discovery and Translational Services Division II-65

Thermo Fisher Scientific Takes Over Proxeon II-65

TriLink BioTechnologies and Nacalai USA Sign Distribution

Agreement II-65

Cell Biosciences Takes Over Alpha Innotech II-65

Eurogentec to Take Over Ana Spec II-66

Merck Takes Over Bangalore Genei II-66

Cell Biosciences Takes Over Protein Forest II-66

Microsoft to Acquire Rosetta Bio Software Assets II-67

CCMB and Bio-Rad India Sign MoU II-67

SAIC-Frederick and Sensor Technologies Ink Collaboration

Agreement II-67

NuSep Signs Purchase Agreement with BioInquire II-68

Intrinsic Bioprobes Bags Contract from NCI II-68

HORIBA Jobin Yvon Acquires GenOptics II-68

Gentel Biosciences Partners with Eprogen II-68

Bruker Daltonics Installs High-Field 15 Tesla and 12 Tesla

FTMS Systems at LUMC II-69

Genedata Extends Collaboration with Roche II-69

AliX Merges with Novalyst Discovery to form NovAliX II-70

BioPike and AnaSpec Sign Agreement II-70

Sigma-Aldrich Purchases Electrophoresis Business of NextGen

Sciences II-70

Fujifilm Purchases Additional Stake in Perseus Proteomics II-71

Sigma-Aldrich Buys Seppro® Depletion Technology and 700

Antibodies II-71

Oxford Gene Technology Purchases Sense Proteomic II-72

Center for Cancer Research Acquires Waters® UPLC/MS Systems II-72



ActivX Biosciences, Inc. (US) II-74

Adnexus Therapeutics (US) II-74

Agilent Technologies, Inc. (US) II-74

Bio-Rad Laboratories, Inc. II-74

Bruker Daltonics, Inc. (US) II-75

Caprion Proteomics, Inc. (Canada) II-75

Digilab Genomic Solutions, Inc. (US) II-76

Dionex Corporation (US) II-76

GE Healthcare (United Kingdom) II-76

Geneva Bioinformatics S.A. (Switzerland) II-76

Hybrigenics SA (France) II-76

Life Technologies Corporation (US) II-77

Millipore Corp. (US) II-77

PerkinElmer, Inc. (US) II-78

Caliper Life Sciences (US) II-78

Shimadzu Biotech (Japan) II-78

Sigma-Aldrich Corporation (US) II-78

Thermo Fisher Scientific (US) II-79

Waters Corp. (US) II-79

Xencor Inc. (US) II-80

Zyomyx, Inc. (US) II-80



Table 1: World Recent Past, Current & Future Analysis for

Proteomics by Geographic Region - US, Canada, Japan, Europe

and Rest of World Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2010 through 2018

(includes corresponding Graph/Chart) II-81


Table 2: World Historic Review for Proteomics by Geographic

Region - US, Canada, Japan, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2004 through 2009 (includes corresponding

Graph/Chart) II-82


Table 3: World 15-Year Perspective for Proteomics by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Canada, Japan, Europe and Rest of World Markets for Years

2004, 2011 and 2018 (includes corresponding Graph/Chart) II-83


Table 4: World Recent Past, Current & Future Analysis for

Proteomics by Segment - Expression Proteomics, Functional

Proteomics and Structural Proteomics Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2010 through 2018 (includes corresponding Graph/Chart) II-84


Table 5: World Historic Review for Proteomics by Segment -

Expression Proteomics, Functional Proteomics and Structural

Proteomics Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2004 through 2009 (includes

corresponding Graph/Chart) II-85


Table 6: World 15-Year Perspective for Proteomics by Segment -

Percentage Breakdown of Dollar Sales for Expression

Proteomics, Functional Proteomics and Structural Proteomics

Markets for Years 2004, 2011 and 2018 (includes corresponding

Graph/Chart) II-86



1-D, 2-D, 3-D II-87

Atmospheric Pressure Ionisation II-87

Electrophoresis II-87

Functional Genomics II-87

High-Throughput II-87

Liquid Chromatography (LC) II-87

Mass Spectrometry (MS) II-87

Matrix-Assisted Laser Desorption Ionisation (MALDI) II-87

Nuclear Magnetic Resonance II-88

X-ray Diffraction II-88

Yeast Two-Hybrid System II-88

2D-PAGE (Two-dimensional PolyAcrylamide Gel Electrophoresis) II-88

TOF (Time of Flight) II-88

Quadrupole II-88

Q-TOF (Quadrupole Time of Flight) II-88

ESI (Electrospray Ionisation) II-88






A.Market Analysis III-1

Outlook III-1

Proteomics Sample Preparation Market III-1

New Product Developments III-1

Strategic Corporate Developments III-6

Select Key Players III-9

B.Market Analytics III-14

Table 7: The US Recent Past, Current & Future Analysis for

Proteomics Market Analyzed with Annual Sales Figures in US$

Million for Years 2010 through 2018 (includes corresponding

Graph/Chart) III-14


Table 8: The US Historic Review for Proteomics Market

Analyzed with Annual Sales Figures in US$ Million for Years

2004 through 2009 (includes corresponding Graph/Chart) III-15



A.Market Analysis III-16

Outlook III-16

New Product Developments III-16

Strategic Corporate Development III-18

Caprion Proteomics, Inc. - A Key Player III-18

B.Market Analytics III-19

Table 9: Canadian Recent Past, Current & Future Analysis for

Proteomics Market Analyzed with Annual Sales Figures in US$

Million for Years 2010 through 2018 (includes corresponding

Graph/Chart) III-19


Table 10: Canadian Historic Review for Proteomics Market

Analyzed with Annual Sales Figures in US$ Million for Years

2004 through 2009 (includes corresponding Graph/Chart) III-20



A.Market Analysis III-21

Shimadzu Biotech - A Key Player III-21

B.Market Analytics III-21

Table 11: Japanese Recent Past, Current & Future Analysis

for Proteomics Market Analyzed with Annual Sales Figures in

US$ Million for Years 2010 through 2018 (includes

corresponding Graph/Chart) III-21


Table 12: Japanese Historic Review for Proteomics Market

Analyzed with Annual Sales Figures in US$ Million for Years

2004 through 2009 (includes corresponding Graph/Chart) III-22



A.Market Analysis III-23

Outlook III-23

Proteomics Research in Europe - An Overview III-23

Table 13: European Proteomics Market (2011): Percentage

Breakdown of Deployment of Proteomics Technologies in

End-Use Segments - Research and Academic Institutions,

Pharmaceutical Companies and Clinical Laboratories

(includes corresponding Graph/Chart) III-24

Protein Identification Market III-24

Protein Separation Market III-24

Market Challenges III-25

Gaining Edge in the Proteomics Industry - Player Strategies III-25

European 2DE Market - Benefiting from Recession III-26

Review of Select Markets III-26

Germany III-26

The United Kingdom III-26

New Product Developments III-27

Strategic Corporate Developments III-28

Select Key Players III-30

B.Market Analytics III-31

Table 14: European Recent Past, Current & Future Analysis

for Proteomics by Geographic Region - France, Germany, UK

and Rest of Europe Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2010 through

2018 (includes corresponding Graph/Chart) III-31


Table 15: European Historic Review for Proteomics by

Geographic Region - France, Germany, UK and Rest of Europe

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2004 through 2009 (includes

corresponding Graph/Chart) III-32


Table 16: European 15-Year Perspective for Proteomics by

Geographic Region - Percentage Breakdown of Dollar Sales for

France, Germany, UK andRest of Europe Markets for Years

2004, 2011 and 2018 (includes corresponding Graph/Chart) III-33



A.Market Analysis III-34

Outlook III-34

Australia III-34

India III-34

Indian Scientific Research towards Functional Genomics and

Proteomics III-34

B.Market Analytics III-35

Table 17: Rest of World Recent Past, Current & Future

Analysis for Proteomics Market Analyzed with Annual Sales

Figures in US$ Million for Years 2010 through 2018 (includes

corresponding Graph/Chart) III-35


Table 18: Rest of World Historic Review for Proteomics

Market Analyzed with Annual Sales Figures in US$ Million for

Years 2004 through 2009 (includes corresponding Graph/Chart) III-36





Total Companies Profiled: 111 (including Divisions/Subsidiaries - 128)


The United States (82)

Canada (4)

Japan (3)

Europe (39)

- France (3)

- Germany (10)

- The United Kingdom (13)

- Spain (1)

- Rest of Europe (12)




To order this report:

Drug_Discovery_and_Development Industry: Global Proteomics Industry


Nicolas Bombourg
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626



SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

@ThingsExpo Stories

SUNNYVALE, Calif., Oct. 20, 2014 /PRNewswire/ -- Spansion Inc. (NYSE: CODE), a global leader in embedded systems, today added 96 new products to the Spansion® FM4 Family of flexible microcontrollers (MCUs). Based on the ARM® Cortex®-M4F core, the new MCUs boast a 200 MHz operating frequency and support a diverse set of on-chip peripherals for enhanced human machine interfaces (HMIs) and machine-to-machine (M2M) communications. The rich set of periphera...

The Internet of Things (IoT) is making everything it touches smarter – smart devices, smart cars and smart cities. And lucky us, we’re just beginning to reap the benefits as we work toward a networked society. However, this technology-driven innovation is impacting more than just individuals. The IoT has an environmental impact as well, which brings us to the theme of this month’s #IoTuesday Twitter chat. The ability to remove inefficiencies through connected objects is driving change throughout every sector, including waste management. BigBelly Solar, located just outside of Boston, is trans...
SYS-CON Events announced today that Matrix.org has been named “Silver Sponsor” of Internet of @ThingsExpo, which will take place on November 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA. Matrix is an ambitious new open standard for open, distributed, real-time communication over IP. It defines a new approach for interoperable Instant Messaging and VoIP based on pragmatic HTTP APIs and WebRTC, and provides open source reference implementations to showcase and bootstrap the new standard. Our focus is on simplicity, security, and supporting the fullest feature set.
Predicted by Gartner to add $1.9 trillion to the global economy by 2020, the Internet of Everything (IoE) is based on the idea that devices, systems and services will connect in simple, transparent ways, enabling seamless interactions among devices across brands and sectors. As this vision unfolds, it is clear that no single company can accomplish the level of interoperability required to support the horizontal aspects of the IoE. The AllSeen Alliance, announced in December 2013, was formed with the goal to advance IoE adoption and innovation in the connected home, healthcare, education, aut...
SYS-CON Events announced today that Red Hat, the world's leading provider of open source solutions, will exhibit at Internet of @ThingsExpo, which will take place on November 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA. Red Hat is the world's leading provider of open source software solutions, using a community-powered approach to reliable and high-performing cloud, Linux, middleware, storage and virtualization technologies. Red Hat also offers award-winning support, training, and consulting services. As the connective hub in a global network of enterprises, partners, a...
The only place to be June 9-11 is Cloud Expo & @ThingsExpo 2015 East at the Javits Center in New York City. Join us there as delegates from all over the world come to listen to and engage with speakers & sponsors from the leading Cloud Computing, IoT & Big Data companies. Cloud Expo & @ThingsExpo are the leading events covering the booming market of Cloud Computing, IoT & Big Data for the enterprise. Speakers from all over the world will be hand-picked for their ability to explore the economic strategies that utility/cloud computing provides. Whether public, private, or in a hybrid form, clo...
Software AG helps organizations transform into Digital Enterprises, so they can differentiate from competitors and better engage customers, partners and employees. Using the Software AG Suite, companies can close the gap between business and IT to create digital systems of differentiation that drive front-line agility. We offer four on-ramps to the Digital Enterprise: alignment through collaborative process analysis; transformation through portfolio management; agility through process automation and integration; and visibility through intelligent business operations and big data.
The Transparent Cloud-computing Consortium (abbreviation: T-Cloud Consortium) will conduct research activities into changes in the computing model as a result of collaboration between "device" and "cloud" and the creation of new value and markets through organic data processing High speed and high quality networks, and dramatic improvements in computer processing capabilities, have greatly changed the nature of applications and made the storing and processing of data on the network commonplace.
Be Among the First 100 to Attend & Receive a Smart Beacon. The Physical Web is an open web project within the Chrome team at Google. Scott Jenson leads a team that is working to leverage the scalability and openness of the web to talk to smart devices. The Physical Web uses bluetooth low energy beacons to broadcast an URL wirelessly using an open protocol. Nearby devices can find all URLs in the room, rank them and let the user pick one from a list. Each device is, in effect, a gateway to a web page. This unlocks entirely new use cases so devices can offer tiny bits of information or simple i...
Things are being built upon cloud foundations to transform organizations. This CEO Power Panel at 15th Cloud Expo, moderated by Roger Strukhoff, Cloud Expo and @ThingsExpo conference chair, will address the big issues involving these technologies and, more important, the results they will achieve. How important are public, private, and hybrid cloud to the enterprise? How does one define Big Data? And how is the IoT tying all this together?
The Internet of Things (IoT) is going to require a new way of thinking and of developing software for speed, security and innovation. This requires IT leaders to balance business as usual while anticipating for the next market and technology trends. Cloud provides the right IT asset portfolio to help today’s IT leaders manage the old and prepare for the new. Today the cloud conversation is evolving from private and public to hybrid. This session will provide use cases and insights to reinforce the value of the network in helping organizations to maximize their company’s cloud experience.
TechCrunch reported that "Berlin-based relayr, maker of the WunderBar, an Internet of Things (IoT) hardware dev kit which resembles a chunky chocolate bar, has closed a $2.3 million seed round, from unnamed U.S. and Switzerland-based investors. The startup had previously raised a €250,000 friend and family round, and had been on track to close a €500,000 seed earlier this year — but received a higher funding offer from a different set of investors, which is the $2.3M round it’s reporting."
The Industrial Internet revolution is now underway, enabled by connected machines and billions of devices that communicate and collaborate. The massive amounts of Big Data requiring real-time analysis is flooding legacy IT systems and giving way to cloud environments that can handle the unpredictable workloads. Yet many barriers remain until we can fully realize the opportunities and benefits from the convergence of machines and devices with Big Data and the cloud, including interoperability, data security and privacy.
All major researchers estimate there will be tens of billions devices - computers, smartphones, tablets, and sensors - connected to the Internet by 2020. This number will continue to grow at a rapid pace for the next several decades. Over the summer Gartner released its much anticipated annual Hype Cycle report and the big news is that Internet of Things has now replaced Big Data as the most hyped technology. Indeed, we're hearing more and more about this fascinating new technological paradigm. Every other IT news item seems to be about IoT and its implications on the future of digital busines...
Cultural, regulatory, environmental, political and economic (CREPE) conditions over the past decade are creating cross-industry solution spaces that require processes and technologies from both the Internet of Things (IoT), and Data Management and Analytics (DMA). These solution spaces are evolving into Sensor Analytics Ecosystems (SAE) that represent significant new opportunities for organizations of all types. Public Utilities throughout the world, providing electricity, natural gas and water, are pursuing SmartGrid initiatives that represent one of the more mature examples of SAE. We have s...
The Internet of Things needs an entirely new security model, or does it? Can we save some old and tested controls for the latest emerging and different technology environments? In his session at Internet of @ThingsExpo, Davi Ottenheimer, EMC Senior Director of Trust, will review hands-on lessons with IoT devices and reveal privacy options and a new risk balance you might not expect.
IoT is still a vague buzzword for many people. In his session at Internet of @ThingsExpo, Mike Kavis, Vice President & Principal Cloud Architect at Cloud Technology Partners, will discuss the business value of IoT that goes far beyond the general public's perception that IoT is all about wearables and home consumer services. The presentation will also discuss how IoT is perceived by investors and how venture capitalist access this space. Other topics to discuss are barriers to success, what is new, what is old, and what the future may hold.
Swiss innovators dizmo Inc. launches its ground-breaking software, which turns any digital surface into an immersive platform. The dizmo platform seamlessly connects digital and physical objects in the home and at the workplace. Dizmo breaks down traditional boundaries between device, operating systems, apps and software, transforming the way users work, play and live. It supports orchestration and collaboration in an unparalleled way enabling any data to instantaneously be accessed on any surface, anywhere and made interactive. Dizmo brings fantasies as seen in Sci-fi movies such as Iro...
There’s Big Data, then there’s really Big Data from the Internet of Things. IoT is evolving to include many data possibilities like new types of event, log and network data. The volumes are enormous, generating tens of billions of logs per day, which raise data challenges. Early IoT deployments are relying heavily on both the cloud and managed service providers to navigate these challenges. In her session at 6th Big Data Expo®, Hannah Smalltree, Director at Treasure Data, to discuss how IoT, Big Data and deployments are processing massive data volumes from wearables, utilities and other mach...
This Internet of Nouns trend is still in the early stages and many of our already connected gadgets do provide human benefits over the typical infotainment. Internet of Things or IoT. You know, where everyday objects have software, chips, and sensors to capture data and report back. Household items like refrigerators, toilets and thermostats along with clothing, cars and soon, the entire home will be connected. Many of these devices provide actionable data - or just fun entertainment - so people can make decisions about whatever is being monitored. It can also help save lives.